Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 1
2006 3
2007 1
2008 3
2009 5
2011 1
2012 3
2013 5
2014 5
2015 5
2016 6
2017 4
2018 6
2019 1
2020 11
2021 22
2022 9
Text availability
Article attribute
Article type
Publication date

Search Results

83 results
Results by year
Filters applied: . Clear all
Page 1
Systemic diseases and the cornea.
Shah R, Amador C, Tormanen K, Ghiam S, Saghizadeh M, Arumugaswami V, Kumar A, Kramerov AA, Ljubimov AV. Shah R, et al. Among authors: arumugaswami v. Exp Eye Res. 2021 Mar;204:108455. doi: 10.1016/j.exer.2021.108455. Epub 2021 Jan 21. Exp Eye Res. 2021. PMID: 33485845 Free PMC article. Review.
ApoE-Isoform-Dependent SARS-CoV-2 Neurotropism and Cellular Response.
Wang C, Zhang M, Garcia G Jr, Tian E, Cui Q, Chen X, Sun G, Wang J, Arumugaswami V, Shi Y. Wang C, et al. Among authors: arumugaswami v. Cell Stem Cell. 2021 Feb 4;28(2):331-342.e5. doi: 10.1016/j.stem.2020.12.018. Epub 2021 Jan 4. Cell Stem Cell. 2021. PMID: 33450186 Free PMC article.
SARS-CoV-2 infection of primary human lung epithelium for COVID-19 modeling and drug discovery.
Mulay A, Konda B, Garcia G Jr, Yao C, Beil S, Villalba JM, Koziol C, Sen C, Purkayastha A, Kolls JK, Pociask DA, Pessina P, de Aja JS, Garcia-de-Alba C, Kim CF, Gomperts B, Arumugaswami V, Stripp BR. Mulay A, et al. Among authors: arumugaswami v. Cell Rep. 2021 May 4;35(5):109055. doi: 10.1016/j.celrep.2021.109055. Epub 2021 Apr 13. Cell Rep. 2021. PMID: 33905739 Free PMC article.
Antiviral drug screen identifies DNA-damage response inhibitor as potent blocker of SARS-CoV-2 replication.
Garcia G Jr, Sharma A, Ramaiah A, Sen C, Purkayastha A, Kohn DB, Parcells MS, Beck S, Kim H, Bakowski MA, Kirkpatrick MG, Riva L, Wolff KC, Han B, Yuen C, Ulmert D, Purbey PK, Scumpia P, Beutler N, Rogers TF, Chatterjee AK, Gabriel G, Bartenschlager R, Gomperts B, Svendsen CN, Betz UAK, Damoiseaux RD, Arumugaswami V. Garcia G Jr, et al. Among authors: arumugaswami v. Cell Rep. 2021 Apr 6;35(1):108940. doi: 10.1016/j.celrep.2021.108940. Epub 2021 Mar 18. Cell Rep. 2021. PMID: 33784499 Free PMC article.
SARS-CoV-2 infection rewires host cell metabolism and is potentially susceptible to mTORC1 inhibition.
Mullen PJ, Garcia G Jr, Purkayastha A, Matulionis N, Schmid EW, Momcilovic M, Sen C, Langerman J, Ramaiah A, Shackelford DB, Damoiseaux R, French SW, Plath K, Gomperts BN, Arumugaswami V, Christofk HR. Mullen PJ, et al. Among authors: arumugaswami v. Nat Commun. 2021 Mar 25;12(1):1876. doi: 10.1038/s41467-021-22166-4. Nat Commun. 2021. PMID: 33767183 Free PMC article.
Metabolic reprogramming and epigenetic changes of vital organs in SARS-CoV-2-induced systemic toxicity.
Li S, Ma F, Yokota T, Garcia G Jr, Palermo A, Wang Y, Farrell C, Wang YC, Wu R, Zhou Z, Pan C, Morselli M, Teitell MA, Ryazantsev S, Fishbein GA, Hoeve JT, Arboleda VA, Bloom J, Dillon B, Pellegrini M, Lusis AJ, Graeber TG, Arumugaswami V, Deb A. Li S, et al. Among authors: arumugaswami v. JCI Insight. 2021 Jan 25;6(2):e145027. doi: 10.1172/jci.insight.145027. JCI Insight. 2021. PMID: 33284134 Free PMC article.
Cold atmospheric plasma for SARS-CoV-2 inactivation.
Chen Z, Garcia G Jr, Arumugaswami V, Wirz RE. Chen Z, et al. Among authors: arumugaswami v. Phys Fluids (1994). 2020 Nov 1;32(11):111702. doi: 10.1063/5.0031332. Phys Fluids (1994). 2020. PMID: 33244211 Free PMC article.
Targeting the coronavirus nucleocapsid protein through GSK-3 inhibition.
Liu X, Verma A, Garcia G Jr, Ramage H, Lucas A, Myers RL, Michaelson JJ, Coryell W, Kumar A, Charney AW, Kazanietz MG, Rader DJ, Ritchie MD, Berrettini WH, Schultz DC, Cherry S, Damoiseaux R, Arumugaswami V, Klein PS. Liu X, et al. Among authors: arumugaswami v. Proc Natl Acad Sci U S A. 2021 Oct 19;118(42):e2113401118. doi: 10.1073/pnas.2113401118. Epub 2021 Sep 30. Proc Natl Acad Sci U S A. 2021. PMID: 34593624 Free PMC article.
Targeting the Coronavirus Nucleocapsid Protein through GSK-3 Inhibition.
Liu X, Verma A, Garcia G, Ramage H, Myers RL, Lucas A, Michaelson JJ, Coryell W, Kumar A, Charney AW, Kazanietz MG, Rader DJ, Ritchie MD, Berrettini WH, Schultz DC, Cherry S, Damoiseaux R, Arumugaswami V, Klein PS. Liu X, et al. Among authors: arumugaswami v. medRxiv. 2021 Jul 21:2021.02.17.21251933. doi: 10.1101/2021.02.17.21251933. Preprint. medRxiv. 2021. PMID: 33655282 Free PMC article. Updated.
83 results